Targeting STING oligomerization with small-molecule inhibitors
Proceedings of the National Academy of Sciences · 15.08.2023 · 120 (33)
DOI: 10.1073/pnas.2305420120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 07.08.2023. Verfasst von Fiachra Humphries und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605. Hauptthemen laut MEDLINE: Membrane Proteins, Interferon Type I. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, Li Weibo Institute for Rare Diseases.
Abstract (Originalsprache)
Stimulator of interferon genes (STING) is an essential adaptor protein required for the inflammatory response to cytosolic DNA. dsDNA activates cGAS to generate cGAMP, which binds and activates STING triggering a conformational change, oligomerization, and the IRF3- and NFκB-dependent transcription of type I Interferons (IFNs) and inflammatory cytokines, as well as the activation of autophagy. Aberrant activation of STING is now linked to a growing number of both rare as well as common chronic inflammatory diseases. Here, we identify and characterize a potent small-molecule inhibitor of STING. This compound, BB-Cl-amidine inhibits STING signaling and production of type I IFNs, IFN-stimulated genes (ISGs) and NFκB-dependent cytokines, but not other pattern recognition receptors. In vivo, BB-Cl-amidine alleviated pathology resulting from accrual of cytosolic DNA in Trex-1 mutant mice. Mechanistically BB-Cl-amidine inhibited STING oligomerization through modification of Cys 148 . Collectively, our work uncovers an approach to inhibit STING activation and highlights the potential of this strategy for the treatment of STING-driven inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605.
- Program in Chemical Biology, Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605.
- Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi 110016, India.
- Mass Spectrometry Facility, Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01545.
- Immunology Research Unit, GlaxoSmithKline, Philadelphia, PA 19426.
ORCID-Profile: Liraz Shmuel-Galia, Zhaozhao Jiang, Jeffrey Y Zhou, Scott A Shaffer, G Scott Pesiridis, Paul R Thompson
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- Li Weibo Institute for Rare Diseases
- UMass Chan OTCV Technology Fund
- UMass Chan Bridge Fund
- HHS|NIH|National Institute of General Medical Sciences
- HHS|NIH|National Institute of Allergy and Infectious Diseases
Zitieren
APA
Humphries, F., Shmuel-Galia, L., Jiang, Z., Zhou, J. Y., Barasa, L., Mondal, S., Wilson, R., Sultana, N., Shaffer, S. A., Ng, S. L., Pesiridis, G. S., Thompson, P. R., & Fitzgerald, K. A. (2023). Targeting STING oligomerization with small-molecule inhibitors. Proceedings of the National Academy of Sciences, 120(33). https://doi.org/10.1073/pnas.2305420120
Vancouver
Humphries F, Shmuel-Galia L, Jiang Z, Zhou JY, Barasa L, Mondal S, et al. Targeting STING oligomerization with small-molecule inhibitors. Proceedings of the National Academy of Sciences. 2023;120(33). doi:10.1073/pnas.2305420120
BibTeX
@article{Humphries2023,
author = {Humphries, Fiachra and Shmuel-Galia, Liraz and Jiang, Zhaozhao and Zhou, Jeffrey Y and Barasa, Leonard and Mondal, Santanu and Wilson, Ruth and Sultana, Nadia and Shaffer, Scott A and Ng, Sze-Ling and Pesiridis, G Scott and Thompson, Paul R and Fitzgerald, Katherine A},
title = {Targeting STING oligomerization with small-molecule inhibitors},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {33},
doi = {10.1073/pnas.2305420120}
}
EUVIMED